Publications by authors named "David B Jackson"

Claim this Profile
P
Plasma exchange in septic shock: are we ready for prime time? CON.
Nathan D Nielsen, David Bradley Jackson, Joao Pedro Teixeira

Intensive Care Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on Pregnancy Outcomes across Trimesters in the United States.
Shiza Virk, Karthik Gangu, Adeel Nasrullah, Aaisha Shah, Zohaa Faiz, David Bradley Jackson

Biomedicines· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD).
David B Jackson, Rebecca Racz, Sarah Kim, Stephan Brock, Keith Burkhart

Pharmaceutics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.
Stephan Brock, David B Jackson, Theodoros G Soldatos, Klaus Hornischer, Anne Schäfer

Front Mol Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COVID-19 explorer-An integrated, whole patient knowledge model of COVID-19 disease.
Stephan Brock, Theodoros G Soldatos, David B Jackson, Francesca Diella, Klaus Hornischer

Front Mol Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors.
Sarah Kim, Gezim Lahu, Majid Vakilynejad, Theodoros G Soldatos, David B Jackson

Clin Transl Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports.
Theodoros G Soldatos, Sarah Kim, Stephan Schmidt, Lawrence J Lesko, David B Jackson

CPT Pharmacometrics Syst Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development.
Sarah Kim, Gezim Lahu, Majid Vakilynejad, Theodoros G Soldatos, David B Jackson

Clin Transl Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting.
Peter Schotland, Rebecca Racz, David B Jackson, Theodoros G Soldatos, Robert Levin

Clin Pharmacol Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.
Yosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, Ikuko Sakamoto, Markus Hartenfeller, David B Jackson

Int J Mol Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.
Anne Schaefer, Christos Sachpekidis, Francesca Diella, Anja Doerks, Anne-Sophie Kratz, David B Jackson

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Oncology-The Quest for Evidence.
Theodoros G Soldatos, Sajo Kaduthanam, David B Jackson

J Pers Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.
Christos Sachpekidis, David B Jackson, Theodoros G Soldatos

Pharmaceuticals (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Event Circumstances and the Case of Drug Interactions.
Theodoros G Soldatos, David B Jackson

Healthcare (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Profiling of Clinical Phenotypes for Human Targets Using Adverse Event Data.
Theodoros G Soldatos, Guillaume Taglang, David B Jackson

High Throughput· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
Linnéa Malgerud, Johan Lindberg, Valtteri Wirta, Maria Gustafsson-Liljefors, Masoud Karimi, David B Jackson

Mol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of "big data" in drug discovery and clinical trials.
Guillaume Taglang, David B Jackson

Gynecol Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin Stimulates Tumor Growth via EphB4.
Sunila Pradeep, Jie Huang, Edna M Mora, Alpa M Nick, Min Soon Cho, David B Jackson

Cancer Cell· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Src activation by β-adrenoreceptors is a key switch for tumour metastasis.
Guillermo N Armaiz-Pena, Julie K Allen, Anthony Cruz, Rebecca L Stone, Alpa M Nick, David B Jackson

Nat Commun· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized cancer medicine--advances and socio-economic challenges.
David B Jackson, Anil K Sood

Nat Rev Clin Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
Alexander Picker, David B Jackson

Expert Rev Mol Diagn· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMT is the dominant program in human colon cancer.
Andre Loboda, Michael V Nebozhyn, James W Watters, Carolyne A Buser, Peter Martin Shaw, David B Jackson

BMC Med Genomics· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug profiling: knowing where it hits.
Alejandro Merino, Agnieszka K Bronowska, David B Jackson, Dolores J Cahill

Drug Discov Today· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular perspectives on the non-responder phenomenon.
David B Jackson

Drug Discov Today· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of the nonresponder phenomenon--implications for systems based discovery.
David B Jackson

Drug Discov Today· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis